Paxil Reanalysis, Mouse Drug Avatars, and Pricey Patties
In this week’s news roundup, Amy Nordrum, a science writer for the International Business Times, talks about a British Medical Journal study that reanalyzed the results of a 14-year-old study on the drug Paxil. The new BMJ study found that the original researchers underreported certain side effects in young patients taking the drug.
Plus, in 2013 Mark Post, based in the Netherlands, made headlines for developing an “in vitro” hamburger that cost a whopping $325,000. But the future of factory-made meat that uses animal stem cells to produce beef, chicken, and maybe even woolly mammoth sausage could be much cheaper and commonplace in the future. Carolyn Mattick, who recently explored this topic in Slate, joins Science Friday to talk about the good and bad of producing cultured meat.
Amy Nordrum is an executive editor at MIT Technology Review. Previously, she was News Editor at IEEE Spectrum in New York City.
Carolyn Mattick is a 2015-2016 AAAS science and technology policy fellow based in Washington, D.C.